Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Phibro Animal Health (PAHC) Debt to Equity (2016 - 2026)

Phibro Animal Health has reported Debt to Equity over the past 13 years, most recently at $0.38 for Q4 2025.

  • For Q4 2025, Debt to Equity fell 27.23% year-over-year to $0.38; the TTM value through Dec 2025 reached $0.38, down 27.23%, while the annual FY2025 figure was $2.21, 81.83% up from the prior year.
  • Debt to Equity for Q4 2025 was $0.38 at Phibro Animal Health, down from $2.01 in the prior quarter.
  • Over five years, Debt to Equity peaked at $2.39 in Q1 2025 and troughed at $0.38 in Q4 2025.
  • A 5-year average of $1.09 and a median of $1.09 in 2022 define the central range for Debt to Equity.
  • Biggest five-year swings in Debt to Equity: crashed 59.83% in 2021 and later skyrocketed 179.29% in 2025.
  • Year by year, Debt to Equity stood at $0.5 in 2021, then skyrocketed by 48.02% to $0.74 in 2022, then soared by 60.96% to $1.2 in 2023, then plummeted by 55.88% to $0.53 in 2024, then fell by 27.23% to $0.38 in 2025.
  • Business Quant data shows Debt to Equity for PAHC at $0.38 in Q4 2025, $2.01 in Q3 2025, and $2.21 in Q2 2025.